CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling
2011 · Oncogene · 155 citations
https://doi.org/10.1038/onc.2011.439
D
Deepak Kanojia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
160
Papers
2.6K
Citations
25
h-index
39
i10-index
Deepak Kanojia is an academic researcher. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Metal complexes synthesis and properties & Click Chemistry and Applications. The author has an h-index of 25, co-authored 136 publications.
ORCID: 0000-0003-4295-4972Papers by this author
worksFABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis
2019 · Oncogene · 110 citations
https://doi.org/10.1038/s41388-019-0893-4
Nonlinear Growth Kinetics of Breast Cancer Stem Cells: Implications for Cancer Stem Cell Targeted Therapy
2013 · Scientific Reports · 53 citations
https://doi.org/10.1038/srep02473
Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice
2012 · PROTEOMICS · 52 citations
https://doi.org/10.1002/pmic.201200103
Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases
2015 · Stem Cells · 51 citations
https://doi.org/10.1002/stem.2109
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
2023 · Nature Communications · 41 citations
https://doi.org/10.1038/s41467-023-36878-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat